<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04377685</url>
  </required_header>
  <id_info>
    <org_study_id>20CH109</org_study_id>
    <secondary_id>IRBN652020/CHUSTE</secondary_id>
    <nct_id>NCT04377685</nct_id>
  </id_info>
  <brief_title>Prediction of Clinical Course in COVID19 Patients</brief_title>
  <acronym>COVID-CTPRED</acronym>
  <official_title>Prediction of Clinical Course in COVID19 Patients Using Unsupervised Classification Approaches of Clinical, Biological and the Multiparametric Signature of the Chest CT Scan Performed at Admission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National des Sciences Appliquées (INSA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre National pour le Recherche Scientifique (CNRS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Jean Monnet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the context of the COVID19 pandemic and containment, chest CT is currently frequently
      performed on admission, looking for suggestive signs and basic abnormalities of COVID19
      compatible viral pneumonitis pending confirmation of identification of viral RNA by
      reverse-transcription polymerase chain reaction(PCR), with a reported sensitivity of 56-88%
      in the first few days, slightly higher than PCR (60%) (1). Nevertheless, currently
      established radiological abnormalities are not specific for COVID19 and the specificity of
      the chest CT is ~25% when PCR is used as a reference (1). Deconfinement and its consequences
      will complicate the triage of COVID patients and the role of the scanner, with the expected
      impact of a decrease in the prevalence of infection in the emergency department and an
      increase in the number of &quot;all-round&quot; patients, including patients with non-COVID viral
      infiltrates or pneumopathies.

      In addition, there are currently no imaging criteria to complement the clinical and
      biological data that can predict the progression of lung disease from the initial data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In image processing, computational medical imaging has demonstrated its ability to predict a
      therapeutic response or a particular evolution after extracting relevant anatomical,
      functional or even non-visually perceptible information from the volume of images, making it
      possible to construct a powerful radiomic signature or to use robust anatomical/functional
      measurements to provide estimates of ventilation or vascular state. By combining these data
      extracted from the scanner with the standard clinical-biological data produced at admission
      during triage, our ambition is to build a predictive model using unsupervised classification
      approaches capable of helping predict clinical evolution with the aim of optimizing the
      management of the resource.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic of COVID disease composite</measure>
    <time_frame>On admission to the hospital</time_frame>
    <description>The diagnostoc of COVID disease is composite of:
CT features wich will include presence/location/laterality of morphological CT abonormal densities (ground glass opacities, consolidations, reticulations),
pulmonary vessels size,
distribution and abnormalities,
local / global CT-ventilation index (CT-VI) severity,
radiomic features (shape features, 1st-order and 2nd order statistics)
Analysis of CT-Scan results.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>COVID 19</condition>
  <arm_group>
    <arm_group_label>COVID19 patients</arm_group_label>
    <description>Patient tested positive for SARS-CoV-2 who had a CT scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT-Scan</intervention_name>
    <description>Chest CT scan on admission to the hospital</description>
    <arm_group_label>COVID19 patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient admitted to the emergency room of COVID-19 confirmed by RT-PCR
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 18 years

          -  clinical suspicion of COVID-19 confirmed by RT-PCR

          -  CT scan at ER admission

          -  RT-PCR sampling

        Exclusion Criteria:

          -  CT scan failure or loss of CT data

          -  RT-PCR initial results unavailable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Pierre CROISILLE, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre CROISILLE, PhD</last_name>
    <phone>0477127584</phone>
    <phone_ext>33</phone_ext>
    <email>pierre.croisille@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Béatrice DEYGAS</last_name>
    <email>beatrice.deygas@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre CROISILLE, PhD</last_name>
      <phone>0477127584</phone>
      <email>Pierre.croisille@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre CROISILLE, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID 19</keyword>
  <keyword>chest CT scan</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

